PMID: 11905765Mar 22, 2002Paper

Vaccines for melanoma: translating basic immunology into new therapies

The Lancet Oncology
Jedd D Wolchok, P O Livingston

Abstract

Advances in molecular biology and immunology in the past 10-15 years have allowed for a greater understanding of the molecules present on melanoma cells that are recognised by the immune system. The rising incidence of melanoma, combined with lack of efficacy of cytotoxic therapies, means there is a significant need for the development of effective immunotherapies. We discuss three types of vaccine for melanoma, which are currently in phase III clinical trials: allogeneic and autologous cellular vaccines, and carbohydrate vaccines. We also discuss several new areas of vaccine development, including DNA vaccines, dendritic-cell-based vaccines, peptide vaccines, and heat-shock protein vaccines. Although initial clinical trials have shown the safety and immunological efficacy of vaccines for melanoma, the true clinical benefit of these strategies will only be revealed in large randomised trials.

References

Oct 1, 1994·Current Opinion in Immunology·P K Srivastava, H Udono
May 28, 1993·International Journal of Cancer. Journal International Du Cancer·N K CheungC Liu
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·D M KlinmanA M Krieg
Jul 3, 1996·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
Dec 1, 1995·Seminars in Cancer Biology·N E Blachere, P K Srivastava
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·S ZhangP O Livingston
Sep 17, 1998·The Journal of Clinical Investigation·L W WeberA N Houghton
Jan 5, 1999·The Journal of Experimental Medicine·O AkbariB Stockinger
Dec 10, 1999·The Journal of Experimental Medicine·W B BowneA N Houghton
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·H M ZarourW J Storkus
Mar 4, 2000·International Journal of Cancer. Journal International Du Cancer·G RagupathiP O Livingston

❮ Previous
Next ❯

Citations

Sep 25, 2003·Vaccine·Nikoletta L KallinterisMinzhen Xu
Aug 6, 2003·Current Opinion in Immunology·Alessandro Sette, John Fikes
Feb 20, 2004·The New England Journal of Medicine·Susan E Krown, Paul B Chapman
Jun 15, 2005·ILAR Journal·Michael K Schunk, G Eileen Macallum
Feb 7, 2006·Biochemistry. Biokhimii︠a︡·E V Dyatlovitskaya, A G Kandyba
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinming YangAnn Richmond
Dec 22, 2009·Acta Veterinaria Scandinavica·Louise B BrøndenAnnemarie T Kristensen
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nand K VyasFlorante A Quiocho
Oct 3, 2008·Melanoma Research·John F ThompsonEric Wachter
Jan 9, 2004·Expert Review of Vaccines·Karl Erik Hellstrom, Ingegerd Hellstrom
Jan 9, 2004·Expert Review of Vaccines·Ruggero RidolfiAngela Riccobon
Apr 6, 2004·Surgical Oncology Clinics of North America·Maher N Younes, Jeffrey N Myers
Dec 3, 2003·Journal of Experimental Therapeutics & Oncology·Darja KanducEmanuel Farber
Jan 13, 2012·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Katharina Tschoep-LechnerRolf-Dieter Issels
Feb 26, 2008·Expert Opinion on Biological Therapy·Marko Lens
May 17, 2008·PPAR Research·Christian FreudlspergerJürgen Hoffmann
Mar 17, 2016·Journal of Oncology Practice·UNKNOWN American Society of Clinical Oncology
Jun 6, 2003·Oncogene·María S Soengas, Scott W Lowe
Feb 23, 2005·Expert Review of Molecular Diagnostics·Gerald P LinetteJeffrey S Ross
Aug 24, 2006·Expert Review of Anticancer Therapy·Lorenzo PillaLicia Rivoltini
Nov 26, 2002·American Journal of Clinical Dermatology·Michael S Sabel, Vernon K Sondak
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Massimo Di NicolaAndrea Anichini
Nov 30, 2010·Surgical Oncology Clinics of North America·Jade HomsiPatrick Hwu
Aug 17, 2006·Genes & Development·Lynda ChinDavid E Fisher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Klaus J Busam
Veterinary and Comparative Oncology
L B BrøndenA T Kristensen
British Medical Journal
W C Hodges
© 2022 Meta ULC. All rights reserved